Copyright
©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 114395
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.114395
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.114395
Table 1 Representative lipid-lowering agents effects on inflammatory and immunomodulatory biomarkers
| Lipid-lowering ingredient | Lipid-modifying | Inflammation and immunomodulation |
| Curcumin-piperine[119] | TG (decrease) | Serum CRP (decrease) |
| Pan-PPAR agonist (lanifibranor)[120] | TG (decrease); LDL-C (decrease); apolipoprotein A1 (decrease); HDL (increase) | CRP (decrease) |
| Aqueous extract of Cichorium intybus seeds[121] | TG (decrease) | Glutathione catalase (decrease); superoxide dismutase (decrease); malondialdehyde (decrease); adiponectin (decrease); TNF-α (decrease); IL-1β (decrease) |
| Aqueous extract of Terminalia chebula[122] | TG (decrease); LDL-C (decrease); TC (decrease); VLDL-C (decrease); HDL (increase) | NO (decrease); GSH (decrease); MDA (decrease); hsCRP (decrease) |
| Rutin flavonoid supplement[123] | TG (decrease); LDL-C (decrease); TC (decrease); HDL (increase) | MDA (decrease); IL-6 (decrease) |
| L-citrulline supplementation[124] | TG (decrease); HDL (increase) | TNF-α (decrease); hs-CRP (decrease) |
| Nano-curcumin[125] | Lipoprotein (a) (decrease) | hs-CRP (decrease) |
| Ellagic acid[126] | TG (decrease); LDL-C (decrease); TC (decrease) | MDA (decrease); CRP (decrease); TNF-α (decrease); IL-6 (decrease); TAC (increase); GPx (increase); SOD (increase) |
| GLP1RA (exenatide)[127] | TG (decrease); HDL (increase) | CRP (decrease); IL-6 (decrease); TNF-α (decrease) |
| GLP1RA (orforglipron)[128] | TG (decrease); LDL-C (decrease); ApoB (decrease); ApoC3 (decrease) | hs-CRP (decrease) |
| Rosuvastatin/ezetimibe[129] | LDL-C (decrease) | Senescent CD8+ T cells (decrease); Treg (decrease); Naive to memory CD8+ T cell (increase) |
- Citation: Yang HY, Wei Y, Mao Q, Zhao LH. Immune activation induced by dysregulated lipid metabolism in the pathogenesis of type 2 diabetes. World J Diabetes 2025; 16(12): 114395
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/114395.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.114395
